Stock NXTC NEXTCURE, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. NextCure, Inc.

Equities

NXTC

US65343E1082

Delayed Nasdaq
Other stock markets
 17:49:50 01/05/2024 BST 		5-day change 1st Jan Change
1.33 USD +9.92% Intraday chart for NextCure, Inc. -7.64% +16.67%
04-08 NextCure, Inc. and LigaChem Biosciences, Inc. Present Preclinical Data on B7-H4 Antibody Drug Conjugate At AACR 2024 CI
04-04 NextCure, Inc. Appoints Rakesh Dixit to Scientific Advisory Board CI

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
HC Wainwright Initiates NextCure With Buy Rating, $7 Price Target
MT
BTIG Lowers NextCure's Price Target to $8 From $27, Maintains Buy Rating
MT
Needham Lowers NextCure's Price Target to $6 From $12, Maintains Buy Rating
MT
Roth Capital Lowers NextCure's Price Target to $4 From $6, Maintains Neutral Rating
MT
Ladenburg Downgrades NextCure to Neutral From Buy
MT
Piper Sandler Adjusts Price Target on NextCure to $6 From $13, Maintains Overweight Rating
MT
Truist Securities Adjusts NextCure's Price Target to $15 From $19, Reiterates Buy Rating
MT
Piper Sandler Lowers NextCure's Price Target to $13 From $21, Maintains Overweight Rating
MT
Ladenburg Thalmann Initiates NextCure at Buy With $16 Price Target
MT
Needham Adjusts Price Target on NextCure to $14 from $30, Keeps Buy Rating
MT
NEXTCURE : Piper Sandler Adjusts NextCure's Price Target to $21 From $26, Maintains Overweight Rating
MT
NEXTCURE : Truist Securities Upgrades NextCure to Buy From Hold; Price Target is $19
MT
NEXTCURE : BofA Securities Downgrades NextCure to Underperform From Neutral, Adjusts Price Target to $10 From $13
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. NXTC Stock
  4. News NextCure, Inc.
  5. Analyst Reco.